| 000 | 01464 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515160258.0 | ||
| 264 | 0 | _c20090421 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 024 | 7 |
_a10.3899/jrheum.080802 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKapoor, Shailendra | |
| 245 | 0 | 0 |
_aAnakinra and its rapidly expanding role in management of nonarthritic systemic disorders. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cFeb 2009 |
||
| 300 |
_a446; author reply 447 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 |
_aEndothelin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPneumonia _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSyndrome |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 36 _gno. 2 _gp. 446; author reply 447 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.080802 _zAvailable from publisher's website |
| 999 |
_c18652282 _d18652282 |
||